课题基金 / 基金详情

IMMUNODETECTION AND IMMUNOPHARMACOLOGIC ELIMINATION OF BREAST/OVARIAN CANCER

IMMUNODETECTION AND IMMUNOPHARMACOLOGIC ELIMINATION OF BREAST/OVARIAN CANCER
乳腺癌/卵巢癌的免疫检测和免疫药理学消除
批准号：
6236976
负责人：
ROBERT C BAST
金额：
$1.28万
依托单位：
DUKE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
项目状态：
已结题
起止时间：
1996-04-01 至 1998-03-31
来源：
https://reporter.nih.gov/project-details/6236976
关键词：
alkylating agents anthracyclines antineoplastics bone marrow purging breast neoplasm /cancer diagnosis female reproductive system disorder diagnosis flow cytometry gene mutation genetic markers immunoconjugates immunocytochemistry immunopharmacology loss of heterozygosity metastasis monoclonal antibody mucins neoplasm /cancer genetics neoplasm /cancer immunotherapy nucleic acid probes ovary neoplasms polymerase chain reaction sex chromosomes subtraction hybridization tumor suppressor genes

项目成果

ROBERT C BAST的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Enhancement Program
Developmental Research Program
The SIK2 Inhibitor GRN-300 Enhances PARP Inhibitor Sensitivity and Cytotoxic T-Cell Function in Ovarian Cancer
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
海外基金